Results 131 to 140 of about 40,961 (260)

Treatment of peripheral exudative hemorrhagic chorioretinopathy by intravitreal injections of ranibizumab

open access: yesClinical Ophthalmology, 2012
Kei Takayama,1 Tosio Enoki,1,2 Teruo Kojima,1,2 Sho Ishikawa,1 Masaru Takeuchi,11Department of Ophthalmology, National Defense Medical College, Saitama, Japan; 2Enoki Clinic, Saitama, JapanAbstract: Peripheral exudative hemorrhagic chorioretinopathy ...
Takayama K   +4 more
doaj  

Intravitreal ranibizumab for myopic choroidal neovascularization: 12-month results [PDF]

open access: yes, 2010
PURPOSE: The purpose of this study was to evaluate the safety and efficacy of intravitreal ranibizumab after 12 months in the treatment of choroidal neovascularization secondary to pathologic myopia.
Cachulo, ML   +8 more
core  

Spectral-domain optical coherence tomography findings in polypoidal choroidal vasculopathy suggest a type 1 neovascular growth pattern

open access: yesClinical Ophthalmology, 2014
Saeed T Alshahrani,1,2 Hanan N Al Shamsi,2 Eman S Kahtani,2 Nicola G Ghazi2,3 1King Fahad Specialist Hospital, Dammam, Saudi Arabia; 2King Khaled Eye Specialist Hospital, Riyadh, Saudi Arabia; 3University of Virginia, Department of Ophthalmology ...
Alshahrani ST   +3 more
doaj  

Bilateral juxtapapillary choroidal neovascularization secondary to Birdshot chorioretinopathy -- case report [PDF]

open access: gold, 2021
Sania Vidas Pauk   +7 more
openalex   +1 more source

Quantitative assessment of the long-term effect of photodynamic therapy in patients with pathologic myopia [PDF]

open access: yes, 2018
Background: In patients with classic subfoveal choroidal neovascularization (CNV) secondary to pathologic myopia (PM), photodynamic therapy (PDT) has been shown to stabilize the visual acuity.
Jochmann, Claudia   +3 more
core  

Role of Erythropoietin Receptor Signaling in Macrophages or Choroidal Endothelial Cells in Choroidal Neovascularization [PDF]

open access: gold, 2022
Aniket Ramshekar   +8 more
openalex   +1 more source

Home - About - Disclaimer - Privacy